Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's what TDA is showing.
Yes and no. It did add static, but at times it was amusing.
What's curious is that all of those who made a big deal about not having a bid, now that we have one, are not dumping!
But it is a government agency
http://www.nih.gov/
And the dumping continues!
There are just a lot of peeps who are dumping trying to exit and that is keeping it down.
NEWS----
XOMA to Develop Therapeutic Antibody for H1N1 and H5N1 Influenza Viruses Under $2.2 Million U.S. Government Program Managed by SRI International
3:00p ET September 23, 2009 (GlobeNewswire)
XOMA Ltd. (Nasdaq:XOMA) expanded its biodefense programs to include the development of a novel antibody that has been shown by Dana-Farber Cancer Institute and Harvard Medical School researchers to neutralize group 1 influenza A viruses, including the H1N1 and the H5N1 strains. The antibody, known as F10, could provide a new alternative to treating both seasonal and pandemic virus infections, particularly for patients who have drug-resistant virus strains, are immunocompromised, or have not been vaccinated.
XOMA will conduct the F10 antibody program under a $2.2 million subcontract with SRI International, a nonprofit scientific research institute based in Menlo Park, California. The subcontract will be funded through the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The F10 antibody binds to a region on group 1 influenza viruses which is present across group 1 influenza A viruses. Because the region undergoes less structural change due to mutation or reassortment than vaccine targets, an antibody that binds to it could potentially be used to treat multiple flu virus strains and be useful over multiple flu seasons. In early studies, the antibody appears to stop the spread of influenza viruses by preventing them from replicating after entering cells.
The antibody was initially developed in the laboratory of Wayne A. Marasco, M.D., Ph.D., Associate Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School. Results from initial evaluations of the antibody were recently published in Nature Structural and Molecular Biology (Sui, et al. 2009, 16(3):265-73).
"The first line of defense against any flu virus is vaccination, although the pandemic outbreak of influenza presents challenges to quickly manufacture enough vaccine to treat the population," said Patrick J. Scannon, M.D., Ph.D. XOMA's Executive Vice President and Chief Medical Officer. "We look forward to advancing the development of a medicine that may neutralize all group 1 influenza viruses and give public health officials a new tool in the fight against pandemic and seasonal viruses."
Dr. Marasco commented, "Individuals who are immunocompromised due to illness or certain medications often cannot generate an appropriate immune response to standard vaccines. An antibody such as the one we developed could be of particular importance for these populations that are already at high risk for serious illness due to influenza."
"We are pleased that XOMA will be working with SRI on this important new project. Our goal is to rapidly optimize the anti-flu antibody for preclinical testing and so that it can be efficiently mass-produced if the need arises," said Steven B. Engle, XOMA's Chairman and Chief Executive Officer. "We are using our advanced antibody development and manufacturing capabilities to produce therapeutic antibodies for important public health threats including SARS, botulinum toxin and now group 1 flu viruses."
XOMA's responsibilities will include the evaluation and optimization of the antibody cell line for growth, productivity, manufacturability and performance in bioreactors, following which XOMA will manufacture the antibody for preclinical studies. XOMA has extensive expertise in the discovery, development, engineering and evaluation of antibody drug candidates to a wide range of infectious diseases and other targets. The company also has significant antibody manufacturing experience and the capacity in its GMP-certified facility to produce large quantities of antibody-based drugs for stockpiling and therapeutic uses.
"XOMA's expertise in the development and manufacture of monoclonal antibodies make them a natural partner in this project, one of several between our organizations," noted Jon Mirsalis, Ph.D., Managing Director of SRI's Biosciences Division and Principal Investigator of the NIAID-funded program. "We are delighted to again have them as a key part of our team."
Last fall, XOMA announced a $65 million multiyear contract to support XOMA's ongoing development of drug candidates towards clinical trials in the treatment of botulism poisoning, a potentially deadly muscle paralyzing disease. NIAID has awarded three contracts for a total of nearly $100 million to XOMA to develop anti-botulism antibodies. The first product candidate resulting from this work, XOMA 3AB, is currently undergoing IND-directed studies. In July, XOMA announced a subcontract with SRI to develop novel antibodies to treat the virus that causes sudden acute respiratory syndrome, or SARS.
Thanks Tex.
Quinn, could you possibly PM the details as well, I'm a freebie.
Thanks
I'm a freebie, is it possible you could PM info or an email address I can contact you at?
Thanks
Weeks???!!! Try a couple of months!!!
No... Wait.... This is still July, I forgot. LOL
IMHO I believe peeps are getting weary of waiting for news and have decided to start dumping their shares and move onto something else. I know I've been considering that this AM.
I've heard rumblings that it's going to be a cold July this fall. LOL
If you come up with some theories, please send our way. Thanks Surfie.
Noooot juuuuusssst yoooouuuuu, ittttttt isssss sloooooooow!
I would like it to be, but that is Coastal Capital Partners, not Acquisition. Different company, but if I remember right, there is some connection between CCP and CCAJ.
Mikey, any input on this?
I searched the web site and could not find that statement, could you provide a link.
Catches the shorts. They have to go out on the market and purchase shares to cover. This is why people should not be so anxious to dump as soon as they received there shares.
Just checked mine as well, Yea! I have ATNP.
I'm in the same boat, hopefully TDA will get them in there shortly.
Same here with TDA, nothing posted yet as of 6:30am cdt
No one really knows for sure, but if a previous poster is correct and they delayed the split one day, then the price is non-split and is down. IMO, if the split is delayed a day, the shorters are using the confusion as an opportunity to cover their A$$e$. Buying pre-split shares cheap because others are believing they are receiving a post-split windfall.
This bad boy is on fire this AM!
Yup, don't know if I can handle to many more of those electricity bills for having to run that AC for so many months now.
We've been hearing that all of July, all 183 days of it. LOL
Need to see the company PR that they have received approval for it to happen.
Isn't taking much buying to move it up.
I wouldn't go quite as far as saying we're laughing.
Tex, correct me if I'm wrong, but today is July 64th, so we should be getting a PR in two days? Cool!
Mikey,
Do you know what's happening with JB, he no longer appears to be showing up in MySpace.
I'm here, just not a whole lot to talk about.
Okay Tex, are we extending July, are we going to begin August and Rick is only 2 days late, or should we just break out the Vodka? LOL
Naw, people are trying to take profits since no one has been able to find any verification of the F/S.
Appreciate it as well Race, anxiously awaiting his response.
Count me in!
Rick's nature of not following through on anything has pretty much bored everyone and they've gone on to more active (with follow through) stocks.
Tex, Rick might be on the Julian calendar instead of the Gregorian calendar, which it might only be July 5th right now. LOL
Some meat from Rick would be nicer.
Because some individuals are so insecure that they can only feel good about themselves if they attempt to trash on others.
It's not the O/S it's the A/S (Authorized shares) that is being raised to 6 billion.